These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236 [TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. Lytle KA; Wong CP; Jump DB PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962 [TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. Depner CM; Philbrick KA; Jump DB J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872 [TBL] [Abstract][Full Text] [Related]
9. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. Coenen KR; Hasty AH Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116 [TBL] [Abstract][Full Text] [Related]
10. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer. Jump DB; Depner CM; Tripathy S; Lytle KA Adv Nutr; 2015 Nov; 6(6):694-702. PubMed ID: 26567194 [TBL] [Abstract][Full Text] [Related]
11. Endurance exercise ameliorates Western diet-induced atherosclerosis through modulation of microbiota and its metabolites. Huang WC; Tung CL; Yang YSH; Lin IH; Ng XE; Tung YT Sci Rep; 2022 Mar; 12(1):3612. PubMed ID: 35256637 [TBL] [Abstract][Full Text] [Related]
12. Attenuation of oxidative stress-induced lesions in skeletal muscle in a mouse model of obesity-independent hyperlipidaemia and atherosclerosis through the inhibition of Nox2 activity. Sfyri PP; Yuldasheva NY; Tzimou A; Giallourou N; Crispi V; Aburima A; Beltran-Alvarez P; Patel K; Mougios V; Swann JR; Kearney MT; Matsakas A Free Radic Biol Med; 2018 Dec; 129():504-519. PubMed ID: 30342191 [TBL] [Abstract][Full Text] [Related]
13. Effects of high dietary fat and cholesterol on expression of PPAR alpha, LXR alpha, and their responsive genes in the liver of apoE and LDLR double deficient mice. Zou Y; Du H; Yin M; Zhang L; Mao L; Xiao N; Ren G; Zhang C; Pan J Mol Cell Biochem; 2009 Mar; 323(1-2):195-205. PubMed ID: 19067122 [TBL] [Abstract][Full Text] [Related]
14. Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice. Depner CM; Torres-Gonzalez M; Tripathy S; Milne G; Jump DB J Nutr; 2012 Aug; 142(8):1495-503. PubMed ID: 22739374 [TBL] [Abstract][Full Text] [Related]
15. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice. Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308 [TBL] [Abstract][Full Text] [Related]
16. Liver-selective γ-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis. Kim K; Yu J; Kang JK; Morrow JP; Pajvani UB Biochem Biophys Res Commun; 2020 Jul; 527(4):979-984. PubMed ID: 32439159 [TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet. Ganguly S; Muench GA; Shang L; Rosenthal SB; Rahman G; Wang R; Wang Y; Kwon HC; Diomino AM; Kisseleva T; Soorosh P; Hosseini M; Knight R; Schnabl B; Brenner DA; Dhar D Cell Mol Gastroenterol Hepatol; 2021; 12(3):891-920. PubMed ID: 34062281 [TBL] [Abstract][Full Text] [Related]